NDC codes

FDA NDC Directory
Product NDC (as listed)72205-227Labeler and product segments. Claims need a package NDC.
Product NDC at billing width72205-0227Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
72205-227-30722050227307220502273030 CAPSULE in 1 BOTTLE (72205-227-30)Marketed from Aug 27, 2026
72205-227-3272205022732722050227322 BLISTER PACK in 1 CARTON (72205-227-32) / 14 CAPSULE in 1 BLISTER PACK (72205-227-13)Marketed from Aug 27, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Fingolimod
Generic name (nonproprietary)
fingolimod
Active ingredients
Fingolimod hydrochloride — .5 mg/1
Dosage form
Capsule
Route
Oral
Labeler
Novadoz Pharmaceuticals LLCNDC labeler code 72205
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 207993
Marketing start
Listing expires
Other FDA classes
Sphingosine 1-Phosphate Receptor Modulators (Mechanism)
Identifiers
Product ID 72205-227_cf02c267-5b60-4b85-be94-83840e630859SPL ID cf02c267-5b60-4b85-be94-83840e630859SPL set ID bd981e18-1766-4a2d-9a9b-965ec960aa06RxCUI 1012895UNII G926EC510TUPC 0372205227309
Pharmacologic class
Sphingosine 1-phosphate Receptor Modulator

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472205022730 followed by a unit qualifier and the quantity

Package 72205-0227-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

Fingolimod Capsules are indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. Fingolimod Capsules are sphingosine 1-phosphate receptor modulator indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in patients 10 years of age and older. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 72205-227

What is NDC 72205-227?
72205-227 is the product NDC for Fingolimod, Fingolimod hydrochloride .5 mg/1 capsule, listed with the FDA by Novadoz Pharmaceuticals LLC. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?
Fingolimod.
What is the active ingredient?
Fingolimod hydrochloride.
Who is the labeler?
Novadoz Pharmaceuticals LLC, NDC labeler code 72205. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Fingolimod?
19 other product NDCs are listed under this name. See all Fingolimod NDCs.
Is there a related HCPCS / J-code?
Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Fingolimod NDCs
ProductStrengthForm · routeLabelerProduct NDCPackage NDCs (11-digit)
FingolimodFingolimod hydrochloride .5 mg/1CapsuleOralCivicaScript LLC82249-38582249-0385-30
FingolimodFingolimod hydrochloride .5 mg/1CapsuleOralAlembic Pharmaceuticals Limited46708-22846708-0228-1046708-0228-30
FingolimodFingolimod hydrochloride .5 mg/1CapsuleOralAlembic Pharmaceuticals Inc.62332-22862332-0228-1062332-0228-30
FingolimodFingolimod hydrochloride .5 mg/1CapsuleOralXLCare Pharmaceuticals Inc.72865-25772865-0257-30
FingolimodFingolimod hydrochloride .5 mg/1CapsuleOralBiocon Pharma Inc.70377-01970377-0019-1170377-0019-21
FingolimodFingolimod hydrochloride .5 mg/1CapsuleOralQuallent Pharmaceuticals Health LLC82009-14382009-0143-30
FingolimodFingolimod hydrochloride .5 mg/1CapsuleOralAurobindo Pharma Limited65862-95265862-0952-0765862-0952-2865862-0952-30
FingolimodFingolimod hydrochloride .5 mg/1CapsuleOralAvKARE42291-04842291-0048-30
FingolimodFingolimod hydrochloride .5 mg/1CapsuleOralTeva Pharmaceuticals, Inc.0480-782000480-7820-56
FingolimodFingolimod hydrochloride .5 mg/1CapsuleOralSun Pharmaceutical Industries, Inc.62756-06462756-0064-5962756-0064-8162756-0064-83+1 more

All 20 Fingolimod NDCs

Other NDCs under ANDA 207993

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 207993
ProductStrengthForm · routeLabelerProduct NDC
FingolimodFingolimod hydrochloride .5 mg/1CapsuleOralApotex Corp.60505-4332

Free account

Log in to keep searching

You’ve used your 3 free searches. Med-Code is free: log in or create a free profile to keep looking up NDCs, J-codes and drugs.

Create a free profileLog in